Showing results (261-270 of 412) with videos related to

Sort By:
Pageof 42
BMC Cancer|July 31, 2016
The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patientsJorge J Castillo, Ilya G Glezerman, Susan H Boklage, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
HIV-negative plasmablastic lymphoma: not in the mouthJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Seminars in Oncology|April 30, 2003
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaRoger G Owen, Steven P Treon, Ayad Al-Katib, et al.
British Journal of Haematology|May 14, 2011
Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemiaSteven P Treon, Guang Yang, Christine Hanzis, et al.
British Journal of Haematology|April 17, 2004
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myelomaNoopur Raje, Teru Hideshima, Faith E Davies, et al.
Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.
Leukemia Research|January 31, 2012
Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studiesJorge J Castillo, John L Reagan, Randall R Ingham, et al.
The American Journal of Dermatopathology|September 20, 2014
Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvementBrady E Beltrán, Jorge J Castillo, Pilar Quiñones, et al.
Leukemia & Lymphoma|March 19, 2024
Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature reviewGilad Itchaki, Osnat Jarhovsky, Jorge J Castillo, et al.
Blood|December 15, 2018
Bruton tyrosine kinase degradation as a therapeutic strategy for cancerDennis Dobrovolsky, Eric S Wang, Sara Morrow, et al.
Pageof 42